| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 03/21/2002 | CA2421234A1 Interferon-alpha induced gene |
| 03/20/2002 | EP1188824A2 Human foam cells and methods for preparing them, monoclonal antibodies to said foam cells and their pharmaceutical and diagnostic use |
| 03/20/2002 | EP1188448A2 Heparin-binding growth factors for gene therapy and anterior eye disorders |
| 03/20/2002 | EP1187931A1 49 human secreted proteins |
| 03/20/2002 | EP1187922A2 Pesticidal proteins |
| 03/20/2002 | EP1187918A1 Tek antagonists |
| 03/20/2002 | EP1187915A2 Compounds for therapy and diagnosis of lung cancer and methods for their use |
| 03/20/2002 | EP1187908A1 42 human secreted proteins |
| 03/20/2002 | EP1187852A1 EXPRESSION AND EXPORT OF INTERFERON-ALPHA PROTEINS AS Fc FUSION PROTEINS |
| 03/20/2002 | EP1187850A1 Antimicrobial theta defensins and methods of using same |
| 03/20/2002 | EP1187849A1 Meth1 and meth2 polynucleotides and polypeptides |
| 03/20/2002 | EP1187843A1 Angiogenic proteins and uses thereof |
| 03/20/2002 | EP1187842A1 Human tumor necrosis factor receptor tr10 |
| 03/20/2002 | EP1187841A1 Method for enhanced protein stabilization and production of cell lines useful for production of such stabilized proteins |
| 03/20/2002 | EP1187591A2 Ibd-associated microbial antigens and methods of using same |
| 03/20/2002 | EP1139101A9 Immunoassay for c-reactive protein |
| 03/20/2002 | EP0800829B1 Antitumor agent potentiator comprising il-6 antagonist |
| 03/20/2002 | EP0628077B1 Humanised antibodies directed against a33 antigen |
| 03/20/2002 | EP0610475B1 Nerve-derived transglutaminase enzyme useful for inducing nerve regeneration |
| 03/20/2002 | EP0593501B1 Biocidal proteins |
| 03/20/2002 | EP0589961B1 Assay systems for neurotrophin activity |
| 03/20/2002 | EP0418316B1 Platelet-specific chimeric immunoglobulin |
| 03/20/2002 | CN1341123A Novel G protein-coupled receptor protein and DNA thereof |
| 03/20/2002 | CN1341121A Expression and export of anti-obesity proteins as Fc fusion proteins |
| 03/20/2002 | CN1341120A 骨刺激因子 Bone stimulator |
| 03/19/2002 | USRE37596 Hybridoma cell line which produces the monoclonal antibody bw sclc-1 having the deposit number ecacc no. 90022110. |
| 03/19/2002 | US6359193 Nucleotide sequences of lats genes |
| 03/19/2002 | US6359127 Oligonucleotide for use in treatment of cancer and nervous system disorders |
| 03/19/2002 | US6359126 Antibodies to αvβ3 integrin |
| 03/19/2002 | US6359117 Lymphocyte controlling polypeptide; for use in the treatment of allergies, hodgkins's disease and lung defects |
| 03/19/2002 | US6359116 Compounds |
| 03/19/2002 | US6358923 Preventing and diagnosing blood, genetic, and nervous system disorders associated with decreased genetic expression |
| 03/19/2002 | US6358741 Polynucleotide coding propagation regulator; for treating cell proliferative defects |
| 03/19/2002 | US6358740 Genetically engineering peptide domains; join homologous and heterologous nucleotide sequences, transcribe artificially joined nucleotide sequences, recover nucleotide sequences |
| 03/19/2002 | US6358732 Nucleotide sequences preferential polypeptides for use in the treatment of defects in central nervous system |
| 03/19/2002 | US6358727 Nucleotide sequences coding binding protein for use in treatment and prevention of infections |
| 03/19/2002 | US6358723 Deoxyribonuclease IIβ proteins and cDNAs |
| 03/19/2002 | US6358711 Generating polyclonal antibody; immunize animal, isolate animal antibodies, screen isolated antibodies with the polypeptide and detect binding of polyclonal antibody |
| 03/19/2002 | US6358710 Humanized antibodies that bind to the antigen bound by antibody NR-LU-13 |
| 03/19/2002 | US6358707 Polynucleotide sequences coding polypeptide associated with cellular secretion; for use in treatment of diabetes, stroke, atherosclerosis, restenosis, thrombosis, autoimmune disease, psoriasis, arthritis, crohn's, and inflammatory defects |
| 03/19/2002 | US6358706 Nucleotide sequences coding membrane protein; for use in treatment of epilepsy, schizophrenia, depression, sleep, stress, muscle, endocrine, respiratory, fertility, contraceptive, cardiovascular disorders and atherosclerosis |
| 03/19/2002 | US6358704 M protein |
| 03/19/2002 | US6358703 Expression system for factor VIII |
| 03/19/2002 | US6358701 A dna molecule encoding a protein; screening agonists and antagonsits; to determining channel modulators that may have insecticidal, mitacidal and/or nematocidal activity |
| 03/19/2002 | US6358695 Determining compounds that activate or inhibit a g-protein receptor by exposing cells expressing the polypeptide on the surface with a test compound to allow binding and detect a signal in response to binding of agent to the polypeptide |
| 03/19/2002 | US6358694 Culturing prostaglandin receptor expressing cells in the presence of a test compound; measure the modulating affects of the compound that interacts with the recombinant receptor and compare the affects with a control host cell |
| 03/19/2002 | US6358693 AMPA-binding human gluR4 receptor methods |
| 03/19/2002 | US6358689 Detection of markers in nascent proteins |
| 03/19/2002 | US6358509 Administering to animal a polypeptide wherein animal produces antibodies against polypeptide, antibodies being able to specifically bind to human il-4 and are able to inhibit binding of human il-4 to cellular receptors |
| 03/19/2002 | CA2099779C Mixed specificity fusion proteins |
| 03/19/2002 | CA2008390C Mutants of human antithrombin iii |
| 03/19/2002 | CA1341348C Human tumor necrosis factor |
| 03/14/2002 | WO2002020848A2 Gene and sequence variation associated with cancer |
| 03/14/2002 | WO2002020847A2 Gene and sequence variation associated with lipid disorder |
| 03/14/2002 | WO2002020818A1 Enhanced in vitro synthesis of active proteins containing disulfide bonds |
| 03/14/2002 | WO2002020817A1 A method of producing fr901228 |
| 03/14/2002 | WO2002020813A2 Recombinant endothelial cell growth inhibitors derived from a mammalian plasminogen |
| 03/14/2002 | WO2002020802A1 A cell line expressing mutant human tissue-type plasminogen activator, constructing strategy and method of expressed protein preparation |
| 03/14/2002 | WO2002020788A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/14/2002 | WO2002020767A2 G-csf analog compositions and methods |
| 03/14/2002 | WO2002020766A2 G-csf analog compositions and methods |
| 03/14/2002 | WO2002020764A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/14/2002 | WO2002020763A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/14/2002 | WO2002020762A2 Tnf receptor-like molecules and uses thereof |
| 03/14/2002 | WO2002020757A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/14/2002 | WO2002020740A2 Proteolysis targeting chimeric pharmaceutical |
| 03/14/2002 | WO2002020736A2 Proteases |
| 03/14/2002 | WO2002020735A2 Enzymes having high temperature polymerase activity and methods of use thereof |
| 03/14/2002 | WO2002020730A2 Manganese lipoxygenase |
| 03/14/2002 | WO2002020728A2 High growth methanotrophic bacterial strain methylomonas 16a |
| 03/14/2002 | WO2002020718A2 Osteoclast-associated receptor |
| 03/14/2002 | WO2002020619A2 HUMAN ANTIBODIES AGAINST PSEUDOMONAS AERUGINOSA LPS DERIVED FROM TRANSGENIC XENOMOUSE$m(3) |
| 03/14/2002 | WO2002020617A1 The identification and development of specific monoclonal antibodies to squamous cell carcinoma |
| 03/14/2002 | WO2002020615A2 Antibody and/or chemokine constructs which bind to a chemokine receptor and their use in immunological disorders |
| 03/14/2002 | WO2002020611A1 Recombinant fusion protein for diagnosis of tsutsugamushi disease |
| 03/14/2002 | WO2002020569A2 Mammalian genes; related reagents and methods |
| 03/14/2002 | WO2002020565A2 Collections of repeat proteins comprising repeat modules |
| 03/14/2002 | WO2002020563A2 RECEPTOR IN THE EDb FIBRONECTIN DOMAIN |
| 03/14/2002 | WO2002020562A2 Family member of inhibitor of apoptosis proteins |
| 03/14/2002 | WO2002020560A1 Novel human cancer/testis antigen and gene thereof |
| 03/14/2002 | WO2002020040A1 Mimetic peptides for epitope of apolipoprotein b-100, concatemer and modified peptides thereof, and the vaccine composition comprising the same |
| 03/14/2002 | WO2002020038A2 Method for down-regulating ige |
| 03/14/2002 | WO2002019837A1 Improved bioactive whey protein hydrolysate |
| 03/14/2002 | WO2001070173A3 Immunokine composition and method |
| 03/14/2002 | WO2001064920A3 Hybrid expression of neisserial proteins |
| 03/14/2002 | WO2001062969A3 Estrogen receptor alpha variants and methods of detection thereof |
| 03/14/2002 | WO2001061007A3 Fibroblast growth factor-23 molecules and uses thereof |
| 03/14/2002 | WO2001058921A9 Methods and compositions for generating angiostatin |
| 03/14/2002 | WO2001058275A9 Use of acid-stable subtilisin proteases in animal feed |
| 03/14/2002 | WO2001057085A3 G-protein coupled receptors |
| 03/14/2002 | WO2001055392A3 Nuclear hormone receptors |
| 03/14/2002 | WO2001040472A3 Streptococcus pneumoniae antigens |
| 03/14/2002 | WO2001036684A3 Mammalian toxicological response markers |
| 03/14/2002 | WO2001023572A3 Polynucleotides and polypeptides encoded thereby |
| 03/14/2002 | WO2001020031A3 Polymorphisms in a klotho gene |
| 03/14/2002 | WO2000058483A9 Protozoan expression system |
| 03/14/2002 | WO2000056899A9 Dsp-2 dual-specificity map kinase phosphatase |
| 03/14/2002 | WO2000055353A9 In vitro macromolecule biosynthesis methods using exogenous amino acids and a novel atp regeneration system |
| 03/14/2002 | WO2000053742A9 Polynucleotides and proteins encoded thereby |
| 03/14/2002 | US20020032323 Polynucleotide and polypeptide sequence information stored on computer readable media |